Status:
UNKNOWN
Nomogram Control of Predictive Factors of Early Withdrawal After Gynecologic Oncology Surgery in the Enhanced Recovery After Surgery (ERAS) Protocol and Assessment of Practices
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Gynecological Cancers
Eligibility:
FEMALE
18+ years
Brief Summary
Validation of a predictive nomogram of a short hospital stay (less than two days after surgery) on a prospective cohort of patients.
Detailed Description
* Validation of a predictive nomogram of short-term hospitalization (less than two days after surgery) * Analysis of the factors influencing the variations of average length of stay * Morbidity analys...
Eligibility Criteria
Inclusion
- All patients who had surgery for gynecological cancer under the ERAS program.
Exclusion
- None
Key Trial Info
Start Date :
January 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 8 2020
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT03470870
Start Date
January 8 2018
End Date
February 8 2020
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli Calmettes
Marseille, Bouches Du Rhone, France, 13009